| Literature DB >> 26973819 |
Juxing Chen1, Guillermo Tellez2, Jeffery Escobar1.
Abstract
Footpad dermatitis (FPD) is a type of skin inflammation that causes necrotic lesions on the plantar surface of the footpads in commercial poultry, with significant animal welfare, and economic implications. To identify biomarkers for FPD development and wound healing, a battery cage trial was conducted in which a paper sheet was put on the bottom of cages to hold feces to induce FPD of broilers. Day-of-hatch Ross 308 male broiler chicks were fed a corn-soybean meal diet and assigned to 3 treatments with 8 cages per treatment and 11 birds per cage. Cages without paper sheets were used as a negative control (NEG). Cages with paper sheets during the entire growth period (d 0-30) were used as a positive control (POS) to continually induce FPD. Cages with paper sheets during d 0-13 and without paper sheets during d 14-30 were used to examine the dynamic of FPD development and lesion wound healing (LWH). Footpad lesions were scored to grade (G) 1-5 with no lesion in G1 and most severe lesion in G5. Covering with paper sheets in POS and LWH induced 99% incidence of G3 footpads on d 13. Removing paper sheets from LWH healed footpad lesions by d 30. One representative bird, with lesions most close to pen average lesion score, was chosen to collect footpad skin samples for biomarker analysis. Total collagen protein and mRNA levels of tenascin X (TNX), type I α1 collagen (COL1A1), type III α1 collagen (COL3A1), tissue inhibitor of metalloproteinase 3 (TIMP3), and integrin α1 (ITGA1) mRNA levels were decreased (P < 0.05), while mRNA levels of tenascin C (TNC), tumor necrosis factor (TNF) α, Toll-like receptor (TLR) 4 and vascular endothelial growth factor (VEGF), IL-1β, and the ratio of MMP2 to all TIMP were increased (P < 0.03) in G3 footpads in POS and LWH compared to G1 footpads in NEG on d 14. These parameters continued to worsen with development of more severe lesions in POS. After paper sheets were removed (i.e., LWH), levels of these parameters gradually or rapidly returned to levels measured in NEG. Regression analysis indicated significant quadratic changes of these parameters to footpad lesion scores. In summary, these biomarkers were interrelated with dynamic changes of footpad lesion scores, suggesting they may be used as potential biomarkers for footpad lesion development and wound healing process.Entities:
Keywords: biomarker; footpad dermatitis; gene expression; lesion development; wound healing
Mesh:
Substances:
Year: 2016 PMID: 26973819 PMCID: PMC4777922 DOI: 10.3389/fcimb.2016.00026
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Diet formulation and nutrient composition.
| Corn | 57.422 | 58.093 | 63.214 |
| Soybean meal, 47.5% CP | 35.813 | 34.165 | 29.517 |
| Soybean oil | 1.896 | 3.663 | 3.61 |
| L-lysineHCl | 0.221 | 0.061 | 0.046 |
| MHA® | 0.298 | 0.2 | 0.154 |
| L-threonine | 0.06 | - - - | - - - |
| L-tryptophan | 0.166 | 0.146 | - - - |
| Dicalcium phosphate 18.5% | 1.283 | 1.037 | 0.928 |
| Limestone | 1.622 | 1.409 | 1.392 |
| Salt | 0.301 | 0.251 | 0.402 |
| Choline chloride 60% | 0.267 | 0.25 | 0.233 |
| Mineral premix | 0.201 | 0.2 | 0.2 |
| Vitamin premix | 0.101 | 0.1 | 0.1 |
| Santoquin® Mixture 6 | 0.02 | 0.02 | 0.02 |
| Myco CURB® | 0.05 | 0.05 | 0.05 |
| Coban® 90 | 0.05 | 0.05 | 0.05 |
| BMD® 60 | 0.03 | 0.03 | 0.03 |
| Sodium bicarbonate | 0.144 | 0.22 | - - - |
| Phyzyme® XP TPT | 0.005 | 0.005 | 0.005 |
| Cibenza® DP100 | 0.05 | 0.05 | 0.05 |
| ME, kcal/kg | 3025 | 3150 | 3200 |
| Crude Protein % | 22 | 21 | 19 |
| Ca % | 1.05 | 0.9 | 0.85 |
| Total P, % | 0.62 | 0.57 | 0.53 |
| Available P, % | 0.5 | 0.45 | 0.42 |
MHA, Santoquin, and Cibenza are registered marks of Novus International, Inc., St. Charles, MO.
Vitamin premix supplied per kilogram of diet: retinol, 9.2 mg; cholecalciferol, 100 μg; dl-α-tocopherol, 90 mg; menadione, 6 mg; thiamine, 6.2 mg; riboflavin, 26.5 mg; pantothenic acid, 39.7 mg; niacin, 100 mg; pyridoxine, 11 mg; folic acid, 4 mg; biotin, 0.3 mg; cyanocobalamin, 0.1 mg.
Mineral premix supplied per kilogram of diet: Mn, 64 mg; Zn, 64 mg; Fe, 37 mg; Cu, 16 mg; I, 0.7 mg; Se, 0.3 mg.
Myco CURB is a registered mark of Kemin Industries, Inc., Des Moines, IA.
Coban is a registered mark of Elanco Animal Health, Indianapolis, IN.
BMD is a registered mark of Zoetis, Inc., Florham Park, NJ.
Phyzyme is a registered mark of Danisco Animal Nutrition, Marlborough, UK.
List of primers used for qRT-PCR.
| TIMP2 | GGATTCAGGGAATGACATTTATGG | ATCTTGATCTGCTTCACTTCGTACTG |
| TIMP3 | CTCCAACTTCGGCCACTCA | CTTCCACCCTCTGGATGCA |
| TIMP4 | TCATCTGCGATTCTGCTTTAGTG | GGCAGGAACCACCTTTTCAC |
| MMP2 | GGACTGTAAACCCTCGAGGAAA | CAGATCAGGCCAGAATGTAGCA |
| VEGF | AGAAAGGCCGGTACAAACCA | AGTGCTTTCTCCTCTCTGAGCAA |
| TNX | AGCCCCTTGAGACCACCTTT | TGCTGAAGGACAGAGCAGTGTAG |
| TNC | GCTCTCAAATTTCTCCTCCAGTCT | CCTTTTCAAAGCTGATGGAGTCTT |
| COL1A2 | GCAGAATACTACCGGGCTGATC | TTTTCAGAGTGGCATCAACTTCA |
| COL3A1 | ATGTGAAGGCTGGCTCAGTTG | GTCCCGGAAAGCCACTAATG |
| ITGA2 | CCCGAATCTGGAACAGTACCTT | TGCCTCAGCAAAGAGTTGCA |
| ITGB1 | GCAAGGTGGAAGTGACTGCAT | CTGCCTGTATACATTCCCCACAT |
| actin | CAACACAGTGCTGTCTGGTGGTA | ATCGTACTCCTGCTTGCTGATCC |
| TNFα | TGTTCTATGACCGCCCAGTTC | GACGTGTCACGATCATCTGGTT |
| TLR4 | AGTCTGAAATTGCTGAGCTCAAAT | GCGACGTTAAGCCATGGAAG |
Growth performance parameters among negative (NEG) and positive (POS) controls, and development and lesion wound healing (LWH) in broiler chickens at different ages.
| Body weight, kg | 0.36 | 0.36 | 0.35 | 0.01 |
| Body weight gain, kg | 0.31 | 0.31 | 0.31 | 0.01 |
| Feed conversion ratio, kg/kg | 1.15 | 1.16 | 1.16 | 0.01 |
| Mortality, % | 4.02 | 0.18 | 2.04 | 1.81 |
| Body weight, kg | 1.60 | 1.54 | 1.65 | 0.02 |
| Body weight gain, kg | 1.55 | 1.49 | 1.61 | 0.02 |
| Feed conversion ratio, kg/kg | 1.37 | 1.46 | 1.37 | 0.01 |
| Mortality, % | 5.51 | 0.34 | 2.88 | 1.78 |
Cages without paper were used as a NEG. Cages with papers during the entire growth period (d 0–30) were used as a POS to continually induce footpad dermatitis. Cages with paper during d 0–13 and without paper during d 14–30 were used to examine the dynamic of FPD development and wound healing (LWH).
Means within a row with different superscripts differ at P < 0.05.
Reported SEM is the average SEM of the individual least-square means.
Figure 1Footpad lesion score among negative (NEG) and positive (POS) controls, and development and lesion wound healing (LWH) in broiler chickens at different ages. Means with different letters differ at P < 0.05.
Figure 2Total collagen protein levels in negative (NEG) and positive (POS) controls, and in lesion wound healing (LWH) broiler chickens at different ages. Means with different letters differ at P < 0.05.
Figure 3Gene expression of COL1A1 (A) and COL3A1 (B) in negative (NEG) and positive (POS) controls, and in development and lesion wound healing (LWH) broiler chickens at different ages. Means with different letters differ at P < 0.05.
Figure 4Gene expression of TNX (A), TIMP3 (B), ITGA2 (C) and ITGB1 (D) in negative (NEG) and positive (POS) controls, and in development and lesion wound healing (LWH) broiler chickens at different ages. There was no interaction between treatments and age for ITGB1 (D), treatment differences in birds at same age were shown in (D). Means with different letters differ at P < 0.05.
Figure 5Gene expression of TNFα (A), TNC (B), TLR4 (C), and VEGF (D) in negative (NEG) and positive (POS) controls, and in development and lesion wound healing (LWH) broiler chickens at different ages. There was no interaction between treatments and age for TNC (B), treatment differences in birds at same age were shown in (B). Means with different letters differ at P < 0.05.
Gene expression of TIMP2, TIMP3, TIMP4, MMP2, IL-1β, and the ratio of MMP2 to TIMP2, TIMP3, TIMP4, and TIMPs in negative (NEG) and positive (POS) controls, and development and lesion wound healing (LWH) in broiler chickens at different ages.
| TIMP2 | 0.742 | 0.496 | 0.496 | 0.035 | < 0.0001 |
| TIMP3 | 0.618 | 0.293 | 0.293 | 0.057 | 0.0006 |
| TIMP4 | 0.607 | 0.320 | 0.320 | 0.085 | 0.027 |
| MMP2 | 0.548 | 0.452 | 0.452 | 0.086 | 0.441 |
| MMP2/TIMP2 | 0.730 | 0.888 | 0.888 | 0.131 | 0.411 |
| MMP2/TIMP3 | 0.827 | 1.541 | 1.541 | 0.133 | 0.001 |
| MMP2/TIMP4 | 0.894 | 2.213 | 2.213 | 0.657 | 0.175 |
| MMP2/TIMP | 0.258 | 0.390 | 0.390 | 0.038 | 0.026 |
| IL-1β | 2.144 | 76.486 | 76.486 | 23.024 | 0.035 |
| TIMP2 | 1.005 | 0.956 | 1.072 | 0.082 | 0.61 |
| TIMP3 | 1.069 | 0.364 | 0.873 | 0.049 | < 0.0001 |
| TIMP4 | 4.053 | 1.844 | 2.691 | 0.587 | 0.045 |
| MMP2 | 1.776 | 1.928 | 1.840 | 0.178 | 0.839 |
| MMP2/TIMP2 | 1.794 | 2.174 | 1.736 | 0.123 | 0.048 |
| MMP2/TIMP3 | 1.680 | 5.504 | 2.158 | 0.611 | 0.0005 |
| MMP2/TIMP4 | 0.477 | 1.784 | 1.171 | 0.345 | 0.049 |
| MMP2/TIMP | 0.303 | 0.735 | 0.465a,b | 0.093 | 0.014 |
| IL-1β | 1.337 | 142.529 | 2.333 | 29.931 | 0.005 |
Means within a row with different superscripts differ at P < 0.05.
Correlation of total collagen protein and mRNA levels of COL1A1, COL3A1, TNFα, TLR4, IL-1β, TNC, VEGF, TNX, ITGA2, ITGB1, TIMP3, TIMP2, TIMP4, MMP2, MMP2/TIMP2, MMP2/TIMP3, MMP2/TIMP4, and MMP2/TIMPs with footpad lesion score.
| Total collagen | 0.545 | < 0.0001 |
| COL1A1 | 0.322 | < 0.0001 |
| COL3A1 | 0.136 | < 0.0001 |
| TNFα | 0.550 | < 0.0001 |
| TLR4 | 0.370 | < 0.0001 |
| IL-1β | 0.308 | 0.0004 |
| TNC | 0.284 | < 0.0001 |
| VEGF | 0.285 | < 0.0001 |
| TNX | 0.245 | < 0.0001 |
| ITGA2 | 0.217 | < 0.0001 |
| ITGB1 | 0.127 | 0.002 |
| TIMP3 | 0.456 | < 0.0001 |
| TIMP2 | 0.166 | 0.0002 |
| TIMP4 | 0.117 | 0.0032 |
| MMP2 | 0.232 | 0.0034 |
| MMP2/TIMP2 | 0.263 | 0.0014 |
| MMP2/TIMP3 | 0.556 | < 0.0001 |
| MMP2/TIMP4 | 0.151 | 0.0294 |
| MMP2/TIMP | 0.348 | 0.0001 |